Indeed, evaluation of the effect of silybinin on the prostate carcinoma DU145 cells and bladder transitional-cell papilloma RT4 cells revealed that silybinin can cause caspase-mediated apoptosis by inhibition of stat3 and increasing the level of p53 protein, respectively 18,19. The gene discussed is TP53; the disease is prostate carcinoma.